Compare FCO & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCO | PETS |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 36.8M |
| IPO Year | N/A | N/A |
| Metric | FCO | PETS |
|---|---|---|
| Price | $2.97 | $1.67 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.20 |
| AVG Volume (30 Days) | 100.1K | ★ 216.6K |
| Earning Date | 01-01-0001 | 02-02-2026 |
| Dividend Yield | ★ 14.96% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | ★ $226,972,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | $12.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.73 | $1.59 |
| 52 Week High | $6.63 | $6.85 |
| Indicator | FCO | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 33.30 |
| Support Level | $2.89 | $1.69 |
| Resistance Level | $3.02 | $1.83 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 60.14 | 17.39 |
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.